Identification of a Novel Transcription Factor Binding Element Involved in the Regulation by Differentiation of the Human Telomerase (hTERT) Promoter

Overview

Journal Mol Biol Cell

Specialties Cell Biology
Molecular Biology

Date 2000 Dec 5

PMID 11102531

Citations 5

Authors

M Tzukerman

C Shachaf

Y Ravel

I Braunstein

O Cohen-Barak

K L Skorecki

Affiliations

Soon will be listed here.

Abstract

Three different cell differentiation experimental model systems (human embryonic stem cells, mouse F9 cells, and human HL-60 promyelocytic cells) were used to determine the relationship between the reduction in telomerase activity after differentiation and the regulation of the promoter for the hTERT gene. Promoter constructs of three different lengths were subcloned into the PGL3-basic luciferase reporter vector. In all three experimental systems, all three promoter constructs drove high levels of reporter activity in the nondifferentiated state, with a marked and time-dependent reduction after the induction of differentiation. In all cases, the smallest core promoter construct (283 nt upstream of the ATG) gave the highest activity. Electrophoretic mobility shift assays revealed transcription factor binding to two E-box domains within the core promoter. There was also a marked time-dependent reduction in this binding with differentiation. In addition, a distinct and novel element was identified within the core promoter, which also underwent time-dependent reduction in transcription factor binding with differentiation. Site-directed mutagenesis of this novel element revealed a correlation between transcription factor binding and promoter activity. Taken together, the results indicate that regulation of overall telomerase activity with differentiation is mediated at least in part at the level of the TERT promoter and provides new information regarding details of the regulatory interactions that are involved in this process.

Citing Articles

Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells.

Zhou C, Steplowski T, Dickens H, Malloy K, Gehrig P, Boggess J PLoS One. 2013; 8(2):e55730.

PMID: 23409030 PMC: 3567109. DOI: 10.1371/journal.pone.0055730.

Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells.

Hara T, Matsumura-Arioka Y, Ohtani K, Nakamura M Cancer Sci. 2008; 99(6):1155-63.

PMID: 18422743 PMC: 11159262. DOI: 10.1111/j.1349-7006.2008.00798.x.

An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells.

Tzukerman M, Rosenberg T, Ravel Y, Reiter I, Coleman R, Skorecki K Proc Natl Acad Sci U S A. 2003; 100(23):13507-12.

PMID: 14573705 PMC: 263844. DOI: 10.1073/pnas.2235551100.

Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression.

McMurray H, McCance D J Virol. 2003; 77(18):9852-61.

PMID: 12941894 PMC: 224601. DOI: 10.1128/jvi.77.18.9852-9861.2003.

Human telomerase and its regulation.

Cong Y, Wright W, Shay J Microbiol Mol Biol Rev. 2002; 66(3):407-25, table of contents.

PMID: 12208997 PMC: 120798. DOI: 10.1128/MMBR.66.3.407-425.2002.

References

Wright W, Brasiskyte D, Piatyszek M, Shay J . Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J. 1996; 15(7):1734-41. PMC: 450086. View

Thomas M, Yang L, Hornsby P . Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase. Nat Biotechnol. 2000; 18(1):39-42. DOI: 10.1038/71894. View

Wright W, Piatyszek M, Rainey W, Byrd W, Shay J . Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996; 18(2):173-9. DOI: 10.1002/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3. View

Vaziri H, Dragowska W, Allsopp R, Thomas T, Harley C, Lansdorp P . Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A. 1994; 91(21):9857-60. PMC: 44916. DOI: 10.1073/pnas.91.21.9857. View

Wu K, Grandori C, Amacker M, POLACK A, Lingner J, Dalla-Favera R . Direct activation of TERT transcription by c-MYC. Nat Genet. 1999; 21(2):220-4. DOI: 10.1038/6010. View

Cuthbert A, Bond J, Trott D, Gill S, Broni J, Marriott A . Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst. 1999; 91(1):37-45. DOI: 10.1093/jnci/91.1.37. View

Liu K, Schoonmaker M, Levine B, June C, Hodes R, Weng N . Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci U S A. 1999; 96(9):5147-52. PMC: 21831. DOI: 10.1073/pnas.96.9.5147. View

Allsopp R, Vaziri H, Patterson C, Goldstein S, Younglai E, Futcher A . Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992; 89(21):10114-8. PMC: 50288. DOI: 10.1073/pnas.89.21.10114. View

Blackburn E, Bhattacharyya A, Gilley D, Kirk K, Krauskopf A, McEachern M . The telomere and telomerase: how do they interact?. Ciba Found Symp. 1997; 211:2-13; discussion 15-9. DOI: 10.1002/9780470515433.ch2. View

10.

Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M . Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 1999; 59(3):551-7. View

11.

Ulaner G, Hu J, Vu T, Giudice L, Hoffman A . Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 1998; 58(18):4168-72. View

12.

Levy M, Allsopp R, Futcher A, Greider C, Harley C . Telomere end-replication problem and cell aging. J Mol Biol. 1992; 225(4):951-60. DOI: 10.1016/0022-2836(92)90096-3. View

13.

Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M . Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 2000; 28(3):669-77. PMC: 102554. DOI: 10.1093/nar/28.3.669. View

14.

Holt S, Aisner D, Shay J, Wright W . Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci U S A. 1997; 94(20):10687-92. PMC: 23449. DOI: 10.1073/pnas.94.20.10687. View

15.

Yashima K, Maitra A, Rogers B, Timmons C, Rathi A, Pinar H . Expression of the RNA component of telomerase during human development and differentiation. Cell Growth Differ. 1998; 9(9):805-13. View

16.

Horikawa I, Cable P, Afshari C, Barrett J . Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 1999; 59(4):826-30. View

17.

Autexier C, Greider C . Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem Sci. 1996; 21(10):387-91. View

18.

Nakayama J, Tahara H, Saito M, Ito K, Nakamura H, Nakanishi T . Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet. 1998; 18(1):65-8. DOI: 10.1038/ng0198-65. View

19.

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

20.

Kim N, Piatyszek M, Prowse K, Harley C, WEST M, Ho P . Specific association of human telomerase activity with immortal cells and cancer. Science. 1994; 266(5193):2011-5. DOI: 10.1126/science.7605428. View